Company Filing History:
4 out of 3,221 
2 out of 4,943 
1 out of 168 
Years Active: 2020-2023
Title: Sreedhara Alavattam: Innovator in Cancer Treatment Formulations
Introduction
Sreedhara Alavattam is a prominent inventor based in South San Francisco, CA (US). He has made significant contributions to the field of cancer treatment through his innovative formulations. With a total of 5 patents, Alavattam's work focuses on improving the efficacy and delivery of therapeutic agents.
Latest Patents
Alavattam's latest patents include groundbreaking advancements in subcutaneous HER2 antibody formulations. These fixed-dose formulations are designed for subcutaneous administration and are aimed at enhancing cancer treatment. His work includes formulations of pertuzumab and co-formulations of pertuzumab and trastuzumab, which are crucial in the fight against cancer. Additionally, he has developed formulations that reduce oxidation, combining proteins with compounds that prevent protein oxidation. This invention not only provides methods for creating such formulations but also offers techniques for screening compounds that can prevent oxidation in protein compositions.
Career Highlights
Throughout his career, Sreedhara Alavattam has worked with leading companies in the pharmaceutical industry, including Genentech, Inc. and Hoffmann-La Roche Inc. His experience in these organizations has allowed him to contribute significantly to the development of innovative cancer therapies.
Collaborations
Alavattam has collaborated with notable professionals in his field, including Jennifer Eng-Wong and Whitney Kirschbrown. These collaborations have further enriched his research and development efforts.
Conclusion
Sreedhara Alavattam's contributions to cancer treatment through his innovative formulations highlight his role as a key inventor in the pharmaceutical industry. His work continues to pave the way for advancements in therapeutic applications.